Verona Pharma (NASDAQ:VRNA) Sets New 12-Month High on Analyst Upgrade
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) reached a new 52-week high on Wednesday after Canaccord Genuity Group raised their price target on the stock from $44.00 to $72.00. Canaccord Genuity Group currently has a buy rating on the stock. Verona Pharma traded as high as $62.00 and last traded at $62.25, […]
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) reached a new 52-week high on Wednesday after Canaccord Genuity Group raised their price target on the stock from $44.00 to $72.00. Canaccord Genuity Group currently has a buy rating on the stock. Verona Pharma traded as high as $62.00 and last traded at $62.25, […]
